These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31403731)

  • 1. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
    Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F
    APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Campanino MR; Mollo A; De Placido G; Insabato L; Zullo F
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):275-286. PubMed ID: 30511743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer.
    Raffone A; Travaglino A; Saccone G; Cieri M; Mascolo M; Mollo A; Insabato L; Zullo F
    APMIS; 2019 Sep; 127(9):597-606. PubMed ID: 31237034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.
    Raffone A; Travaglino A; Saccone G; Mascolo M; Insabato L; Mollo A; De Placido G; Zullo F
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):287-299. PubMed ID: 30511741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment: A systematic review and meta-analysis.
    Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
    Acta Obstet Gynecol Scand; 2018 Dec; 97(12):1415-1426. PubMed ID: 30168854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Viggiani M; Giampaolino P; Insabato L; Mollo A; De Placido G; Zullo F
    Arch Gynecol Obstet; 2019 Jun; 299(6):1511-1524. PubMed ID: 30915635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women.
    Norimatsu Y; Moriya T; Kobayashi TK; Sakurai T; Shimizu K; Tsukayama C; Ohno E
    Ann Diagn Pathol; 2007 Apr; 11(2):103-8. PubMed ID: 17349568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
    Xiong Y; Xiong YY; Zhou YF
    Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliable Identification of Endometrial Precancers Through Combined Pax2, β-Catenin, and Pten Immunohistochemistry.
    Aguilar M; Chen H; Rivera-Colon G; Niu S; Carrick K; Gwin K; Cuevas IC; Sahoo SS; Li HD; Zhang S; Zheng W; Lucas E; Castrillon DH
    Am J Surg Pathol; 2022 Mar; 46(3):404-414. PubMed ID: 34545858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps.
    Lucas E; Niu S; Aguilar M; Molberg K; Carrick K; Rivera-Colon G; Gwin K; Wang Y; Zheng W; Castrillon DH; Chen H
    Am J Surg Pathol; 2023 Sep; 47(9):1019-1026. PubMed ID: 37314146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
    Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
    Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria.
    Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
    Histopathology; 2019 Apr; 74(5):676-687. PubMed ID: 30347477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial Intraepithelial Neoplasia (EIN) in endometrial biopsy specimens categorized by the 1994 World Health Organization classification for endometrial hyperplasia.
    Li XC; Song WJ
    Asian Pac J Cancer Prev; 2013; 14(10):5935-9. PubMed ID: 24289604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YTHDF2 is a novel diagnostic marker of endometrial adenocarcinoma and endometrial atypical hyperplasia/ intraepithelial neoplasia.
    Bian PP; Liu SY; Luo QP; Xiong ZT
    Pathol Res Pract; 2022 Jun; 234():153919. PubMed ID: 35512522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
    Zhou WX; Liang ZY; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of endometrium hyperplasia and screening of endometrial intraepithelial neoplasia in histopathological images using a global-to-local multi-scale convolutional neural network.
    Zhao F; Dong D; Du H; Guo Y; Su X; Wang Z; Xie X; Wang M; Zhang H; Cao X; He X
    Comput Methods Programs Biomed; 2022 Jun; 221():106906. PubMed ID: 35671602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer.
    Travaglino A; Raffone A; Saccone G; De Luca C; Mollo A; Mascolo M; De Placido G; Insabato L; Zullo F
    Am J Clin Pathol; 2019 Apr; 151(5):529-538. PubMed ID: 30715091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
    Acta Obstet Gynecol Scand; 2019 Aug; 98(8):976-987. PubMed ID: 30779338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.
    Moreno-Bueno G; Hardisson D; Sarrió D; Sánchez C; Cassia R; Prat J; Herman JG; Esteller M; Matías-Guiu X; Palacios J
    J Pathol; 2003 Apr; 199(4):471-8. PubMed ID: 12635138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.